Alexandria Capital, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.

Quarter-by-quarter ownership
Alexandria Capital, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2021$681,000
-0.6%
8,323
+10.8%
0.06%
-1.6%
Q2 2021$685,000
-2.8%
7,509
-8.9%
0.06%
-9.9%
Q1 2021$705,000
-9.4%
8,2430.0%0.07%
-13.4%
Q4 2020$778,000
+6.6%
8,243
-1.8%
0.08%
-5.7%
Q3 2020$730,000
-0.4%
8,3930.0%0.09%
-8.4%
Q2 2020$733,000
+7.0%
8,393
+1.0%
0.10%
-15.2%
Q1 2020$685,000
-18.6%
8,314
-6.5%
0.11%
-0.9%
Q4 2019$842,000
-11.6%
8,889
-18.9%
0.11%
-19.9%
Q3 2019$952,000
-9.4%
10,954
-4.8%
0.14%
-6.0%
Q2 2019$1,051,000
-13.3%
11,509
-8.7%
0.15%
-14.8%
Q1 2019$1,212,000
+9.7%
12,609
-2.1%
0.18%
-2.2%
Q4 2018$1,105,000
-49.8%
12,879
-49.6%
0.18%
-44.4%
Q3 2018$2,202,000
+4.3%
25,557
-8.6%
0.32%
+2.2%
Q2 2018$2,112,000
-9.4%
27,956
-3.0%
0.32%
-8.4%
Q1 2018$2,330,000
-3.9%
28,818
-0.2%
0.35%
-2.3%
Q4 2017$2,425,000
+17221.4%
28,888
+17955.0%
0.35%
+8750.0%
Q3 2017$14,000
+7.7%
1600.0%0.00%
+33.3%
Q2 2017$13,000
+8.3%
1600.0%0.00%0.0%
Q1 2017$12,0000.0%1600.0%0.00%0.0%
Q4 2016$12,000
-7.7%
1600.0%0.00%
+50.0%
Q3 2016$13,0000.0%1600.0%0.00%0.0%
Q2 2016$13,000
+8.3%
1600.0%0.00%0.0%
Q1 2016$12,000
-14.3%
1600.0%0.00%
-50.0%
Q4 2015$14,000
-6.7%
1600.0%0.00%0.0%
Q3 2015$15,000
-6.2%
1600.0%0.00%0.0%
Q2 2015$16,0000.0%1600.0%0.00%
-33.3%
Q1 2015$16,000
+14.3%
160
-20.0%
0.01%
-14.3%
Q2 2013$14,0002000.01%
Other shareholders
NOVARTIS A G shareholders Q2 2020
NameSharesValueWeighting ↓
EXENCIAL WEALTH ADVISORS, LLC 188,514$13,713,0005.95%
PRENTISS SMITH & CO INC 136,441$10,133,0005.74%
MANAGED ASSET PORTFOLIOS, LLC 204,985$15,225,0005.46%
Osher Van de Voorde Investment Management 108,725$8,075,0004.40%
BROWN BROTHERS HARRIMAN & CO 10,796,684$801,870,0004.35%
SECTORAL ASSET MANAGEMENT INC 472,296$35,077,0004.10%
PROFESSIONAL ADVISORY SERVICES INC 235,347$17,479,0003.87%
Elefante Mark B 5,619$417,0003.78%
SPHERA FUNDS MANAGEMENT LTD. 255,000$18,959,0003.71%
CGOV Asset Management 997,161$98,662,0003.61%
View complete list of NOVARTIS A G shareholders